Associate Professor
Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA
Duarte, California, United States
CROSS should be used as the Neoadjuvant Regimen for Patients with Resectable GEJ Adenocarcinomas
Saturday, March 23, 2024
10:00am – 10:15am ET
Saturday, March 23, 2024
11:17am – 11:23am ET